What is PepGen Earnings Power Value (EPV)?
As of Sep24, PepGen's earnings power value is $3.68. *
* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.
Margin of Safety is
N/A.
The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.
PepGen Earnings Power Value (EPV) Historical Data
The historical data trend for PepGen's Earnings Power Value (EPV) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PepGen Earnings Power Value (EPV) Chart
|
PepGen Annual Data
|
|
Trend |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Earnings Power Value (EPV) |
|
- |
- |
- |
- |
|
PepGen Quarterly Data
|
|
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
| Earnings Power Value (EPV) |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of PepGen's Earnings Power Value (EPV)
For the Biotechnology subindustry, PepGen's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PepGen's Earnings Power Value (EPV) Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PepGen's Earnings Power Value (EPV) distribution charts can be found below:
* The bar in red indicates where PepGen's Earnings Power Value (EPV) falls into.
PepGen Earnings Power Value (EPV) Calculation
Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.
The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.
PepGen Business Description
Traded in Other Exchanges
N/A
Address
321 Harrison Avenue, 8th Floor, Boston, MA, USA, 02118
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Executives
| Michelle L Mellion |
officer: See Remarks |
PEPGEN INC., 245 MAIN ST., CAMBRIDGE MA 02142 |
| Niels Svenstrup |
officer: See Remarks |
PEPGEN INC., 245 MAIN ST., CAMBRIDGE MA 02142 |
| Ra Capital Healthcare Fund Lp |
director, 10 percent owner |
200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
| James G Mcarthur |
director, officer: President and CEO |
NIGHTSTAR THERAPEUTICS PLC, 203 CRESCENT STREET, SUITE 303, WALTHAM MA 02453 |
| Jaya Goyal |
officer: See Remarks |
PEPGEN INC., 245 MAIN ST., CAMBRIDGE MA 02142 |
| Habib J Dable |
director |
C/O ACCELERON PHARMA INC., 128 SIDNEY STREET, CAMBRIDGE MA 02139 |
| James E Flynn |
10 percent owner, other: *Possible Member of 10% Group |
780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
| Oxford Science Enterprises Plc |
10 percent owner |
46 WOODSTOCK ROAD, OXFORD X0 OX2 6HT |
| Laurie Keating |
director |
300 THIRD STREET, CAMBRIDGE MA 02142 |
| Christopher Ashton |
director |
PEPGEN INC., 245 MAIN ST., CAMBRIDGE MA 02142 |
| Deerfield Management Company, L.p. (series C) |
10 percent owner, other: *Possible Member of 10% Group |
345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
| Noel Donnelly |
officer: Chief Financial Officer |
PEPGEN INC., 245 MAIN ST., CAMBRIDGE MA 02142 |
| Sonia Bracegirdle |
officer: See Remarks |
PEPGEN INC., 245 MAIN ST., CAMBRIDGE MA 02142 |
| Deerfield Mgmt V, L.p. |
10 percent owner, other: *Possible Member of 10% Group |
345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
| Deerfield Private Design Fund V, L.p. |
10 percent owner, other: *Possible Member of 10% Group |
780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PEPG has been successfully added to your